Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
European Journal of Radiology 77 (2011) 281–286 Contents lists available at ScienceDirect European Journal of Radiology journal homepage: www.elsevier.com/locate/ejrad Diffusion-weighted MRI in cervical lymph nodes: Differentiation between benign and malignant lesions Anna Perrone a , Pietro Guerrisi a , Luciano Izzo b , Ilaria D’Angeli c,∗ , Simona Sassi a , Luigi Lo Mele a , Marina Marini a , Dario Mazza a,1 , Mario Marini a a b c Department of Radiological Sciences, “Sapienza” University, Policlinico Umberto I, Rome, Italy Department of General Surgery “Pietro Valdoni”, “Sapienza” University, policlinico Umberto I, Rome, Italy Department of Heart and Great Vessels “Attilio Reale”, “Sapienza” University, Policlinico Umberto I, Rome, Italy a r t i c l e i n f o Article history: Received 24 March 2009 Received in revised form 28 July 2009 Accepted 31 July 2009 Keywords: MRI Lymph nodes Malignant lesions a b s t r a c t Objective: Purpose of our study was to assess the potential role of diffusion-weighted imaging (DWI) in the differential diagnosis between benign and malignant nodes. Subject and methods: We enrolled 32 subjects: 14 with benign lymphadenopathy, 17 patients with histologically proved malignant disease before beginning treatment and 1 patient with lymphoma after chemotherapeutic treatment. In all patients we used fast spin echo T2-weighted images in axial and coronal planes, fast spin echo T1-weighted images before and after contrast medium of administration in axial and coronal planes. Before contrast administration diffusion sequences were acquired on the axial and coronal plane (b factor of 0.500 and 1000 s/mm2 ) and then apparent diffusion coefficient (ADC) maps were reconstructed. Results: On diffusion images, 13/14 patients with benign nodes showed low signal intensity and had high signal on ADC maps, whereas all patients with malignant diseases appeared hyperintense on diffusion images and with low signal intensity on ADC maps. Only a patient with tuberculosis showed a low ADC value. The mean ADC value of malignant nodes was about 0.85 × 10−3 mm2 /s, the mean value of benign nodes was 1.448 × 10−3 mm2 /s; this difference was statistically significant (p < 0.01). The mean ADC value of treated nodes was 1.75 × 10−3 mm2 /s. The best threshold value was 1.03 × 10−3 mm2 /s, obtaining a sensitivity of 100% and a specificity of 92.9%. Conclusions: Diffusion imaging could be considered an important supportive tool for the diagnosis of enlarged cervical lymphadenopathies. © 2009 Elsevier Ireland Ltd. All rights reserved. 1. Introduction The detection of cervical nodes metastasis is very important for the prognosis and the treatment of head and neck tumours. Up to today parameters used by conventional imaging techniques are shape, size, extracapsular spread and an abnormal inner architecture. The size is certainly the most used criterion for the diagnosis, whereas the presence of central necrosis is the most reliable sign of malignity [1]. Nevertheless several reports showed that these parameters are not enough to discriminate benign from malignant lesions [2,3]. ∗ Corresponding author at: Department of Heart and Great Vessels “Attilio Reale”, La Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy. Tel.: +39 339 4761533. E-mail address: [email protected] (I. D’Angeli). 1 Free professional dentistry. 0720-048X/$ – see front matter © 2009 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.ejrad.2009.07.039 Diffusion-weighted MR imaging (DWI) analyzes intercellular water motion: every change in the water protons movements produces a variation of signal intensity in diffusion-weighted sequences and as a consequence on ADC maps [4]. Purpose of our study was to assess the potential role of DWI in the differential diagnosis between benign and malignant nodes. 2. Materials and methods 2.1. Patients Our study was performed on 32 patients with enlarged neck nodes who underwent Magnetic Resonance exam from November 2007 to March 2009. The study cohort included 14 patients (8 males and 6 females; mean age: 57 ± 10.8 years; range: 24–80 years) with benign lymphadenopathy (1 patient with tuberculosis, 3 with abscesses, 10 with a non-specific lymphadenitis), and 17 patients (10 males and 7 females; mean age: 63 ± 12.8 years; range: 15–85 years) 282 A. Perrone et al. / European Journal of Radiology 77 (2011) 281–286 with histologically proved malignant disease before beginning treatment (7 patients with lymphoma, 9 with squamous cell carcinoma and one patient with rabdomyosarcoma). Moreover we studied a patient with Hodgkin lymphoma after chemotherapeutic treatment. Written informed consent was obtained from all patients. 2.2. MR technique and image analysis All the exam were performed with a 1.5-T superconductive scanner (Avanto, Siemens Medical Systems, Enlargen, Germany) using a standard head–neck coil. In all patients the following protocol was used: - Fast spin echo (FSE) T2-weighted images (TR 5722 ms, TE 95 ms, slice-thickness: 3 mm) in axial plane; - Fast spin echo (FSE) T2-weighted images (TR 3850 ms, TE 75 ms, slice-thickness: 5 mm), in coronal plane; - Fast spin echo (FSE) T1-weighted images, with and without fat suppression (TR 708 ms, TE 75 ms, slice-thickness: 3 mm) in axial plane; - Fast spin echo (FSE) T1-weighted images, with fat saturation after contrast medium of administration (Omniscan, GE Healthcare); in axial and coronal planes. in all three orthogonal planes (X, Y, Z) with a b factor of 0.500 and 1000 s/mm2 per axis in each patient. The ADC value was automatically reconstructed by a standard software imager in the main console. The whole-node ADC value was obtained drawing a region of interest (ROI) covering all the pathologic node in all sections in which it was present and averaging the results. In the study we chose only the largest abnormal adenopathies and excluded from analysis the necrotic areas. 2.3. Statistical analysis Two experienced radiologists analyzed the results obtained independently; disagreements regarding image findings were resolved with a mutual accord. For each patient, both in the benign group and in the malignant group, the average of ADC values of examined nodes was calculated. Statistical analysis was done by using the SPSS (“Statistical Package for Social Science”) program software on the 21 untreated patients. We used Student’s t-test to compare between two groups and a value of p < 0.05 was considered significant. Subsequently we used a receiver operating characteristic (ROC) curve to evaluate diagnostic capability of ADC value and to determine the cut-off value for differentiating malignant from benign nodes. 3. Results Before contrast administration Single-Shot Echo-planar diffusion sensitized sequences (DWI) (TR 8500, TE 99, Matrix 192 × 96, slice-thickness 5 mm, bandwidth1582) were acquired on the axial and coronal plane. The diffusion-sensitizing gradients were applied On DWI images in 13/14 cases with inflammatory diseases lymph nodes showed low signal intensity (b = 1000), whereas on the ADC maps it presented high signal (Fig. 1). Fig. 1. Patient with lymphadenitis. (A). Axial FSE-T2-weighted image showing an enlarged cervical node on the left side. (B) On axial diffusion-weighted MR image at b = 0 s/mm2 the node shows high signal intensity while on diffusion-weighted MR images (C) at b = 1000 s/mm2 the same node is hypointense. (D) On ADC map the lymph nodes is hyperintense with an ADC value = 1.52 × 10−3 mm2 /s. A. Perrone et al. / European Journal of Radiology 77 (2011) 281–286 283 Fig. 2. Patient with tuberculosis. (A) Coronal FSE-T2-weighted image showing multiple enlarged neck nodes on the left side. (B) Diffusion-weighted image at b = 0 s/mm2 shows that nodes have high SI. (C) In the diffusion image at b = 1000 s/mm2 the same nodes exhibit high signal intensity. (D) On ADC map the lymph nodes show low SI; the mean ADC value of the lymph node is 0.91 × 10−3 mm2 /s. Only in the patient with tuberculosis, the ADC value was low as for the malignant group (Fig. 2). In fact the cases with malignant disease appeared hyperintense on diffusion images (b = 1000) and with low signal intensity on ADC maps (Figs. 3 and 4). The mean ADC value of metastatic and lymphomatous nodes was about 0.85 × 10−3 mm2 /s (range: 0.581 × 10−3 –1.03 × 10−3 mm2 /s), lower than the mean value of benign nodes (1.448 × 10−3 mm2 /s, range: 0.91 × 10−3 –2.246 × 10−3 mm2 /s); this difference was statistically significative (p < 0.01) with t = 3.7497 (Table 1). In the only patient treated with CHT lymph nodes were hypointense on DWI (b = 1000) and hyperintense on the ADC maps with a mean value of 1.75 × 10−3 mm2 /s (Fig. 5). The best threshold value for differentiating malignant from benign nodes was 1.03 × 10−3 mm2 /s, obtaining a sensitivity of 100% and a specificity of 92.9% (Fig. 6). Fig. 7 shows the receiver operating characteris- Table 1 Histogram relative to the distribution of ADC values among the examined patients. tic (ROC) curve of the ADC value used for differentiating benign from malignant lymph nodes. The area under the curve was 0.983. 4. Discussion The evaluation of cervical nodes is important not only for diagnosis and staging of malignant diseases, but also for planning treatment and follow-up. Even if ultrasound image, contrast-enhanced computed tomographic and contrast-enhanced MRI allow the detection of enlarged cervical lymphodenopathies, none of these methods reaches the ideal accuracy [5,6]. US guided fine needle aspiration biopsy (US-FNAB) of lymph nodes has been shown to be an accurate method but it is an invasive and operator-dependent exam with a high incidence of false-negative cases [7,8]. Moreover these imaging methods use standard parameters (shape, size, internal architecture, extranodal diffusion and vascular features) that showed to be scarsely reliable [2,3]. SPECT (single photon emission CT) and PET (photon emission tomography) are new image techniques which supply functional information (blood flow and glucidic metabolism) but they are invasive (exposure to radiations), expensive, low available and with a relatively low spatial resolution [9–11]. Recently diffusion-weighted imaging with Magnetic Resonance was introduced which could improve the diagnostic accuracy in the differential diagnosis between benign and malignant nodes [12,13]. Magnetic Resonance with diffusion-weighted imaging is a noninvasive technique that measures the motion of water in the 284 A. Perrone et al. / European Journal of Radiology 77 (2011) 281–286 Fig. 3. Patient with Hodgkin lymphoma. (A) Axial T2-weighted image showing multiple enlarged cervical nodes on the right side that present homogenous high SI, except for a small necrotic area excluded from measurements. (B and C) Both on diffusion-weighted images at b = 0 and at 1000 s/mm2 one, the lymph nodes are hyperintense. (D) ADC map shows hypointensity of lymphomatous nodes with a value of 0.62 × 10−3 mm2 /s. It can see that signal intensity of necrotic area is opposite to nodes. Fig. 4. Patient with carcinoma of the tongue (arrow). (A) Axial T2-weighted image shows an enlarged node on the right side. (B) Diffusion-weighted image at b = 0 s/mm2 shows that node is hyperintense as well as in the (C) diffusion image at b = 1000 s/mm2 . (D) On ADC map the node appears hypointense with an ADC value of 0.71 × 10−3 mm2 /s. A. Perrone et al. / European Journal of Radiology 77 (2011) 281–286 285 Fig. 5. Patient with nasopharingeal carcinoma. (A) Axial T2-weighted image shows multiple enlarged nodes on the both sided. (B) Diffusion-weighted image at b = 0 s/mm2 shows that nodes are hyperintense as well as in the (C) diffusion image at b = 1000 s/mm2 . (D) On ADC map the node shows low signal intensity with an ADC value of 0.76 × 10−3 mm2 /s. extracellular space. As showed in several studies, metastatic nodes present a reduction of diffusivity, which can be attributed to a hypercellularity, to an increased nuclear-to-cytoplasmatic ratio and to perfusion [13]. Above all, in the cases of lymphoma the increate cellularity and the reduced extracellular space have an important role. However this restriction in diffusion in metastatic nodes is represented as an area of hyperintensity on diffusion images with a low value of ADC. Only few authors have examined characterization of head and neck lesions with diffusion-weighted MR imaging [13–17]. In our series we considered 14 subjects with benign diseases who showed enlarged cervical nodes and 17 patients with known malignant lymph nodes (metastasis or lymphoma) before treatment. The evaluation with DWI showed that metastatic and lymphomatous nodes appeared hyperintense (b = 1000 mm2 /s) and hypointense on ADC maps; adversely inflammatory nodes were hypointense (b = 1000 mm/s) and hyperintense on ADC maps. So mean ADC value for malignant lesions, that was 0.85 × 10−3 mm2 /s, resulted lower than benign ones, that was 1.448 × 10−3 mm2 /s (t = 3.7497 per p < 0.01). The best ADC threshold value for distinguishing benign from malignant nodes was 1.03 × 10−3 mm2 /s, with a sensitivity of 100% and a specificity of 92.9%. This value Fig. 6. The mean ADCs of benign and malignant nodes are compared. The horizontal line is our threshold value (1.03 × 10−3 mm2 /s): the ADCs of benign nodes are significantly higher than those of malignant nodes, except for patient with tuberculosis. Fig. 7. Receiver operating characteristic (ROC) curve of the ADC value used for differentiating benign from malignant lymph nodes. The area under the curve is 0.983. 286 A. Perrone et al. / European Journal of Radiology 77 (2011) 281–286 of specificity is due to a case of benign lymphadenopathy which showed a lower value than cut-off one: in tuberculosis (0.934 × 10−3 mm2 /s) this restriction on DWI can be due to the presence of inflammatory cells in the pus that impede the motion of water molecules. Many author analyzed the capability of DWI to differentiate between several causes of lymph nodes. Both Chang et al. [18] and Wang et al. [13] reported a threshold value of 1.22 × 10−3 mm2 /s, with a sensitivity of 91% and a specificity of 93%, accordingly with our results. Razek et al. [14] in a recent study reported metastatic mean ADC value lower than benign ones, with a cut-off value of 1.38 × 10−3 mm2 /s, obtaining a sensitivity of 98% and a specificity of 88%. Our data are not in agreement with Sumi et al. [12,15] who found, for metastatic nodes, significantly higher mean ADC value (1.167 ± 0.447 × 10−3 mm2 /s) than flogistic lymphadenopathies (0.652 ± 0.101 × 10−3 mm2 /s) and than lymphomatous ones (0.601 ± 0.427 × 10−3 mm2 /s). Differences among these studies can be attributed to several causes. Above all, the choice of the b values: a lower b values increase signal-to-noise ratio but makes worsen the sensitivity to diffusion. Other factors are the selection of the region of interest on ADC maps and the use of sequences which reduce the artefacts in order to make more precise the measurement of the interested area. 4.1. Limits Our study has some limits such as a small study cohort. In fact, our statistical tests were performed on the number of the patients rather than the number of involved nodes, in order to avoid bias or confounding effects. Moreover the patients with lymphoma were not treated surgically, but with radio and/or chemotherapy so the malignancy of nodes was assessed by imaging criteria. Another limitation was represented by the low spatial resolution of echoplanar imaging that worsens using high b values (b = 1000 s/mm2 ), that on the other hand are necessary to improve the sensitivity of diffusion imaging. For this reason the small nodes with a diameter inferior to 9 mm are difficult to detect on ADC maps. 5. Conclusions We found a significant difference between benign and malignant cervical nodes on diffusion-weighted imaging and on ADC maps, identifying a threshold ADC value equal to 1.03 × 10−3 mm2 /s. This value, at our opinion, could be used not only in a pre-treatment phase, but also after therapy to detect recurrent disease or as sign of improvement. That is demonstrated by our most important data: the case of post-chemotherapy Hodgkin lymphoma with hypointense nodes on diffusion sequences and hyperintensity on ADC maps, indicative for improvement. In summary, diffusion imaging could be considered an important supportive tool for the diagnosis of enlarged cervical lymphadenopathies. References [1] King AD, Tse GM, Ahuja AT, et al. Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US. Radiology 2004;230:720–6. [2] Van den Brekel MW, Castelijns JA, Snow GB. The size of lymph nodes in the neck on sonograms as a radiologic criteria for metastasis: how reliable is it? AJNR Am J Neuroradiol 1998;19(4):695–700. [3] Van den Brekel MW, Castelijns JA, Snow GB. Detection of lymph node metastases in the neck, radiologic criteria. Radiology 1994;192(3):617–8. [4] Rowley H, Grant E, Roberts T. Diffusion MR imaging. Theory and application. Neuroimaging Clin North Am 1999;9:343–61. [5] Curtin HD, Ishwaran H, Mancouso AA, et al. Comparison of CT and MR imaging in staging of neck metastsis. Radiology 1998;207:123–30. [6] Esen G. Ultrasound of superficial lymph nodes. Eur J Radiol 2006;58:345–59. [7] Van den Breckel MWM, Castelijns JA, Stel HV, et al. Occult metastatic neck disease: detection with US and US-guided fineneedle aspiration cytology. Radiology 1991;180:457–61. [8] Van den Breckel MWM, Castelijns JA, Stel HV, et al. Modern imaging techniques and ultrasound guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993;250:11–7. [9] Yamazaki Y, Saitoh M, Notani K, et al. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Am Nucl Med 2008;22:177–84. [10] Jeong HS, Baek CH, Son YI, et al. Use of integrated (18)F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 2007;29(3):203–10. [11] Kotani J, Kawabe J, Higashiyama S, et al. Evaluation of diagnostic abilities of Ga-SPECT for head and neck lesions. Ann Nucl Med 2008;22(4):297–300. [12] Sumi M, Van Cauteren M, Nakamura T. MR microimaging of benign and malignant nodes in the neck. Am J Radiol 2006;186:749–57. [13] Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion/weighted eco planar MR imaging. Radiology 2001;220: 621–30. [14] Razek AAKA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006;16:1468–77. [15] Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 2003;24:1627–34. [16] Herneth AM, Czerny C, Krestan C. Role of diffusion weighted MRI in the characterization of lymph node metastasis. In: XVI International Congress of Head and Neck Radiology. 2003. [17] King AD, Ahuja AT, Yeung DK, et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 2007;245(3):806–13. [18] Chang VHF, Fan YF, Khoo JBK. MRI features of cervical nodal necrosis in metastatic diseases. Clin Radiol 1996;51:103–9.